SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-03-032431
Filing Date
2003-11-21
Accepted
2003-11-21 18:19:30
Documents
1
Period of Report
2003-11-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd23631.html 4  
1 FORM 4 rrd23631.xml 4 4812
  Complete submission text file 0001181431-03-032431.txt   6825
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Issuer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address AMGEN INC., ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address AMGEN INC., ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 8054471000
ODRE STEVEN M (Reporting) CIK: 0001183886 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12477 | Film No.: 031019196